Bio-Path Holdings falls on wider Q1 loss
** Shares of biotech firm Bio-Path Holdings Inc BPTH.O
down 2.46% at $1.48
** Co reports Q1 net loss of $5.3 mln, or $0.66 per share,
vs a net loss of $3.4 mln, or $0.47 per share, a year earlier
** Post cash balance of $6.7 mln as at March 31, 2023
** BPTH stock down 1.86% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia